Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting

v2.4.1.9
Segment Reporting
3 Months Ended
Mar. 31, 2015
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting
The Company evaluates performance based on the operating income (loss) of the respective business segments. The segment results may not represent actual results that would be expected if they were independent, stand-alone businesses. Segment information is as follows (in thousands):
Balance Sheet Data:
As of March 31, 2015
 
Ligand
 
CyDex
 
Total
Total assets
$
193,081

 
$
70,142

 
$
263,223

 
 
 
 
 
 
 
As of December 31, 2014
 
Ligand
 
CyDex
 
Total
Total assets
$
184,215

 
$
73,814

 
$
258,029

 
 
 
 
 
 
Operating Data:
For the three months ended March 31, 2015
 
Ligand
 
CyDex
 
Total
Net revenues from external customers
$
9,006

 
$
5,596

 
$
14,602

Depreciation and amortization expense
53

 
597

 
650

Operating income
458

 
2,891

 
3,349

Interest expense, net
2,973

 

 
2,973

Income tax expense from continuing operations
14

 
1

 
15

 
 
 
 
 
 
 
For the three months ended March 31, 2014
 
Ligand
 
CyDex
 
Total
Net revenues from external customers
$
6,791

 
$
9,167

 
$
15,958

Depreciation and amortization expense
66

 
602

 
$
668

Operating (loss) income
(71
)
 
5,171

 
$
5,100

Interest expense, net
248

 

 
$
248

Income tax expense from continuing operations
51

 
2

 
$
53